Table 1.
Patients’ demographics.
| Demographics | BCG (n = 148) | Placebo (n = 151) | p-value |
|---|---|---|---|
| Age (mean ± SD) | 40.4 ± 13.6 | 42.8 ± 11.8 | 0.14 |
| BMI | 29.3 ± 18.5 | 26.7 ± 4.2 | 1 |
| Female gender N (%) | 86 (58.1) | 96 (63.6) | 0.29 |
| Symptomatic on admission N (%) | 118 (79.7) | 122 (80.8) | 0.88 |
| Childhood BCG Scar N (%) | 139 (93.9) | 140 (92.7) | 0.83 |
| Diabetes N (%) | 10 (6.8) | 8 (5.3) | 1 |
| Hypertension N (%) | 30 (20.3) | 27 (17.9) | 1 |
| Cardiopathy N (%) | 4 (2.7) | 1 (0.7) | 0.20 |
| Obesity N (%) | 15 (10.1) | 10 (6.6) | 1 |
| Chronic kidney disease N (%) | 0 (0) | 0 (0) | – |
| Chronic pulmonary disease N (%) | 10 (6.8) | 2 (1.3) | 0.039 |
| Sinusitis N (%) | 25 (16.9) | 23 (15.2) | 0.77 |
| Respiratory allergies N (%) | 20 (13.5) | 17 (11.3) | 0.76 |
| Hemoglobinopathies N (%) | 1 (0.7) | 0 (0) | 0.48 |
| Autoimmune disorder N (%) | 0 (0%) | 2 (1.3) | 0.50 |
| Others N (%) | 47 (31.8) | 51 (33.8) | 0.58 |
BCG = Bacillus Calmette-Guérin; n = number of participants; Others = rinitis, hypothyroidism, gastritis, depression, arthrosis, dyslipidemia, glaucoma, among others; SD = standard deviation.